The beneficial effects of ciprofloxacin on survival and hapatic regenerative activity in a rat model of fulminant hepatic failure

Hepatology

Volumn 27, Issue 2, 1998, Pages 533-536

  Kaita, Kelly D E ^b   Assy, Nimar ^b   Gauthier, Tony ^b   Zhang, Manna ^b   Meyers, Adrienne F A ^b   Minuk, Gerald Y ^a  

^a HEALTH SCIENCES CENTRE   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CYCLINE; GALACTOSAMINE; PUTRESCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; DOSE RESPONSE; LIVER CIRRHOSIS; LIVER FAILURE; LIVER REGENERATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STOMACH LAVAGE; SURVIVAL RATE;

ALANINE TRANSAMINASE; ANIMALS; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; DISEASE MODELS, ANIMAL; DNA; IMMUNOHISTOCHEMISTRY; LIVER FAILURE; LIVER REGENERATION; MALE; NORFLOXACIN; PROLIFERATING CELL NUCLEAR ANTIGEN; PUTRESCINE; RATS; RATS, SPRAGUE-DAWLEY; SURVIVAL RATE; TIME FACTORS;

EID: 0031915547     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510270230     Document Type: Article

References (17)

1. Lee WM. Acute liver failure. Am J Med 1994;96(Suppl 1A):3S-8S.
2. Kaita KDE. Treatment of fulminant hepatic failure: is there a light at the end of the tunnel? Can J Gastroenterol 1995;9:319-326.
3. Campbell DA, Ham JM, McCurry KR, Lucey MR, Turcotte JG, Merion RM. Liver transplant for fulminant hepatic failure. Am Surg 1991;57:546-549.
4. Gove CD, Hughes RD. Liver regeneration in relationship to acute liver failure. Gut 1991:592-596.
5. Koenig H, Goldstone AD, Lu CY. Blood-brain barrier breakdown in cold-injured brain is like to a biphasic stimulation of ornithine decarboxylase activity and polyamine synthesis: both are coordinately inhibited by verapamil, dexamethasone, and aspirin. J Neurochem 1989;52:101-109.
6. Genedani s, Bernardi M, Tagliavine S, Botticelli H, Bertolini A. Antidiuretic and nephrotoxic effects of putrescine in rats. Pharmacol Res 1991;23:95-103.
7. Minuk GY, Gauthier T, Gaharie A, Murphy LJ. The effect of GABA on serum and hepatic polyamine concentrations after partial hepatectomy in rats. HEPATOLOGY 1991;14:685-689.
8. Boggust WA, Al-Nakib T. Promotion and suppression of tumor growth and cell proliferation by acetylputrescine and putrescine and their oxidation products acetylGABA and GABA. IRCS Med Sci 1986;14:175-175.
9. Minuk GY, Gauthier T. The effect of gamma-aminobutyric acid on hepatic regenerative activity following partial hepatectomy in rats. Gastroenterology 1993;104:217-221.
10. Minuk GY, Gauthier T, Zhang XK, Wang GQ, Burczynski FJ. Ciprofloxacin reverses the inhibitory effects of acute ethanol exposure on hepatic regeneration in the rat. HEPATOLOGY 1995;22:1797-1800.
11. Zhang M, Song G, Minuk GY. The effects of hepatic stimulator substance, Chinese herbal medicine, selenium/vitamin E and ciprofloxacin on hepatic fibrosis in rats. Gastroenterology 1996;110:1150-1155.
12. Nishiguchi S, Kuroki T, Takeda T, Nakajima S, Shiomi S, Seki S, Matsui-Yuasa I, et al. Effects of putrescine on D-galactosamine-induced acute liver failure in rats. HEPATOLOGY 1990;12:348-353.
13. Keppler D, Lesch R, Reutter W, Decker K. Experimental hepatitis induced by DF-galactosamine. Exp Mol Pathol 1968;9:279-290.
14. Blitzer BL, Waggoner JG, Jones EA, Gralnick HR, Towne D, Butler J, Weise V, et al. A model of fulminant hepatic failure in the rabbit. Gastroenterology 1978;74:664-671.
15. Luk GD. Essential role of polyamine metabolism in hepatic regeneration; inhibition of deoxyribonucleic acid and protein synthesis and tissue regeneration by difluoromethylornithine in the rat. Gastroenterology 1986;90:1261-1267.
16. Tsuji A, Sato H, Kume Y, Tamai I, Okezaki E, Nagata O, Kato H. Inhibitory effects of quinolone antibacterial agents on γ-aminobutyric acid binding to receptor sites in rat brain membranes. Antimicrob Agents Chemother 1988;32:190-194.
17. Cuervas-Mons V, Barrios C, Garrido A, Escartin P, Areas M, Portero F, Mora NP, et al. Bacterial infections in liver transplant patients under selective decontamination with norfloxacin. Transplant Proc 1989;21:35-58.